Background Trastuzumab is a monoclonal antibody selectively directed against Her2 and
approved for the treatment of Her2 overexpressing breast cancer patients. Its proposed …

The status of axillary nodes is the most important prognostic factor in breast cancer to select
patient subgroups for adjuvant chemotherapy; the current standard of care for surgical …

Introduction Gastrointestinal metastases from breast cancer are rare. One large series
reported a rate of 0.7% of gastrointestinal metastatic manifestations from breast cancer, but …

The available data on the natural history of pheochromocytomas and paragangliomas after
radical surgery are heterogeneous and discordant. The aim of our retrospective multicenter …

Background Retroperitoneal sarcomas (RPS) should be surgically managed in specialized
sarcoma centers. However, it is not clearly demonstrated if clinical outcome is more …

Background To evaluate the feasibility and activity of gemcitabine and vinorelbine as a
second/third-line approach in patients with advanced breast cancer. Methods Entered into …

Importance Although active surveillance for patients with low-risk prostate cancer (LRPC)
has been recommended for years, its adoption at the population level is often limited …

Background In the northwestern Italian region of Piedmont, current statistics on
hospitalizations show that surgical treatment for ovarian cancer (OC) is taking place in many …

Background Effective management of pain associated with metastatic bone disease is
paramount in the care of cancer patients. Bisphosphonates are recommended in treating …

Introduction: Chemotherapy-induced nausea, vomiting, and retching (CINVR) remains a
common side effect of treatment. Most previous studies have focused on vomiting control; …